Overview
Enzymit develops a cell-free biomanufacturing platform using AI-designed enzymes to produce high-purity hyaluronic acid (HA) and specialty carbohydrates from simple sugars. Their GMP-ready, animal-free process delivers pharmaceutical- and cosmetic-grade HA with selectable molecular weights from 20 kDa to 4 MDa, low endotoxin levels (≤0.05 EU/mg), and ≥99% purity. This technology scales linearly from kg to tonnes, reducing water, energy, and CO₂ compared to traditional fermentation.
Frequently asked questions
- What capabilities does Enzymit offer for HA production?
- Enzymit produces ultra-pure hyaluronic acid via a cell-free enzymatic process using AI-designed enzymes, enabling customizable molecular weights from 20 kDa to 4 MDa with ≥99% assay and ≤0.05 EU/mg endotoxin.
- Is Enzymit's process regulatory compliant for pharma?
- Yes, their process is GMP-ready, animal-free, and delivers pharmaceutical-grade HA suitable for APIs, with demonstrated pilot-scale production at 200 liters yielding multi-kilogram quantities.
- What geographies does Enzymit operate in?
- Enzymit is based in Israel (Rehovot/Ness Ziona) with partnerships in the Netherlands (Cosun, NIZO), supporting scalable production for global pharma and cosmetics markets.